Watch | COVID-19 Bulletin: Another Indian Firm Gets Approval for Trials of Potential COVID Drug

Name: Watch | COVID-19 Bulletin: Another Indian Firm Gets Approval for Trials of Potential COVID Drug - The Wire
Uploaded: 2020-05-22T11:30:56+05:30
Channel: The Wire
Description: Earlier this month, Glenmark Pharmaceuticals became the first pharma company in India to get the nod to conduct trials on the drug Favipiravir.

Earlier this month, Glenmark Pharmaceuticals became the first pharma company in India to get the nod to conduct trials on the drug Favipiravir.

Pawanjot Kaur

Earlier this month, Glenmark Pharmaceuticals became the first pharma company in India to get the nod to conduct trials on the drug Favipiravir.

watch covid 19 bulletin another indian firm gets approval for trials of potential covid drug

Indian pharmaceutical Strides Pharma Science has received regulatory approval to start clinical trials of antiviral drug Favipiravir, which has been touted as a potential treatment for COVID-19. The company has received approval from the Drug Controller General of India to conduct human studies of favipiravir in the country.

Favipiravir is manufactured under the brand name Avigan by a unit of Japan’s Fujifilm Holdings. Earlier this month, Glenmark Pharmaceuticals became the first pharma company in India to get the nod to conduct trials on the drug. The results of this study are expected by July or August.

This article went live on May twenty-second, two thousand twenty, at thirty minutes past eleven in the morning.

The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.